Lung CT
RayscapeProduct specifications |
Information source:
Vendor
Last updated: May 25, 2023 |
General | |
---|---|
Product name | Lung CT |
Company | Rayscape |
Subspeciality | Chest |
Modality | CT |
Disease targeted | Lung cancer, COVID19 |
Key-features | Nodules detection, nodules localization, nodules measurements, volume calculation, diameter calculation, malignancy score, automatic comparison of nodules, SARS-Cov2, SARS-CoV2 lesion quantification |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps) After: diagnosis verification |
Data characteristics | |
Population | Rayscape Lung CT can be used for adults, clinical population and screening population. |
Input | 3D, contrast, non-contrast, multi-slice, single-slice, slice thickness <3mm |
Input format | DICOM |
Output | Nodules detection and localization overlay, table of calculated measurements, table with nodules evolution |
Output format | DICOM GSPS, DICOM SR, DICOM SC |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class I
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 05-2021 |
Distribution channels | Infinitt |
Countries present (clinical, non-research use) | 5 |
Paying clinical customers (institutes) | 100 |
Research/test users (institutes) | 6 |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of analyses |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance |
|
Other relevant papers |
|